Answers are grounded in this paper and cite their sources.
Observational studies suggest that adequate vitamin D nutrition may reduce the risk of MS and affect the course of the disease. Inherent limitations in these studies, however, preclude a causal interpretation. Randomized controlled clinical trials are the next step to addressing whether vitamin D prevents MS or can favorably affect the course and progression of MS. Here we briefly review the current literature on vitamin D and MS, both as a risk factor and potential treatment for MS with a focus on the issues and challenges in designing prevention and treatment clinical trials.
No takes yet. Share an insight, caveat, or question.
Munger et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: